The mission of AOSSM is to be the premier global, sports medicine organization representing the interests of orthopaedic surgeons and other professionals who provide comprehensive health services for the care of athletes and active people of all ages and abilities. We cultivate evidence-based knowledge, provide extensive educational programming, and promote emerging research that advances the science and practice of sports medicine.


Cabaud Memorial Award: Use of Platelet-Rich Plasma Immediately Post-Injury to Accelerate Ligament Healing was not Successful in an In Vivo Animal Mode
Cartilage Repair with Mesenchymal Stem Cells (MSCs) Delivered in a Novel Chondroitin Sulfate/Polyethylene Glycol Hydrogel in a Rabbit Animal Model
Stem Cells
Injectables and Adjuvants in Cartilage Repair Surgery
Choosing the correct PRP product for your patient
Biologics: Financially Feasible?
Adjuvant Biologics with Cartilage Repair: Theoretical and Practical
Biologics and Cuff Repair
The Role of Platelet-Rich Plasma in Promoting Cartilage Integration and Chondrocyte Migration
Influence of Naproxen, Age and Body Mass Index on the Biological Composition of Leukocyte Rich Platelet-Rich Plasma
Biologics and the Knee: What Should You Be Using
Biologics and OA: What is the Evidence
What Biologics Work Best for Meniscus Repair - How to Easily Do This in the OR
Prospective Randomized Trail of Biologic Augmentation with Mesenchymal Stem Cells in Patients Undergoing Arthroscopic Rotator Cuff Repair
The Subacromial Bursa is a Viable Source of Autologous Mesenchymal Stem Cells for Rotator Cuff Repair
Characterization of Growth Factors, Cytokines, and Hemokines in Bone Marrow Concentrate and Platelet-Rich  Plasma: A Prospecitve Analysis
Biological Augemention for ACL Repair and Reconstruction: This is What will Truly Help Out Outcomes
When to Use PRP and When to Use BMAC? Why the Difference?
Meniscus Repair Outcomes with and without Bone Marrow Aspiration Concentrate
The Cost Variability  of Orthobiologics
Characterizing the Biological Constituents of Platelet-Poor Plasma - Do the Platelets Matter? A Prospecive Cohort Study
Two Cases in 20: Biologics State of the Art for Athletic Injuries
How to Integrate Biologics into Your Practice - Financially Speaking
Two Cases in 30: Cartilage and Biologics Conundrums - My Solutions
The Acute Knee Effusion - Biologics to the Rescue?